Most patients with malignant disease of the lungs will, at some time in their course, require palliative therapy. Previously, this has centered on radiotherapy for non-small cell and chemotherapy and/or radiotherapy for small cell tumors. The prospects for those who remain symptomatic or whose symptoms recur after maximum tolerated radiotherapy are bleak. Symptomatic therapy with […]